Skip to main content
Clinical Trials/KCT0007075
KCT0007075
Not yet recruiting
未知

Optimal Dose of Remimazolam for Sedation During Spinal Anesthesia in Age 60+: A Preliminary Study

Korea University Anam Hospital0 sites20 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Diseases of the musculoskeletal system and connective tissue
Sponsor
Korea University Anam Hospital
Enrollment
20
Status
Not yet recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional Study
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\. Patients who agreed to the clinical trial and scheduled for orthopedic surgery under spinal anesthesia
  • 2\. Patients over 60 years of age, ASA physical status classification system I\-III

Exclusion Criteria

  • 1\. Patients who do not consent to clinical trials
  • 2\. Patients with spinal anesthesia level higher than T6
  • 3\. Patient with previous spine surgery
  • 4\. Patients with body mass index (BMI) \<18 or \>30 kg/m2
  • 5\. Patients who are chronic alcoholics or who are taking psychiatric medications for a long time
  • 6\. Patients with a history of allergy to previous general anesthetics, patients with hypersensitivity to other benzodiazepines

Outcomes

Primary Outcomes

Not specified

Similar Trials